The aim of this guidance paper of the European Psychiatric Association (EPA) is to provide evidence-based recommendations on the early intervention in clinical high-risk (CHR) states of psychoses as assessed according to the EPA guidance on early detection. These recommendations were derived from the current empirical evidence and a meta-analysis on the efficacy of psychological and pharmacological interventions in CHR samples. Studies had to investigate conversion rate and/or functioning as treatment outcome in CHR patients defined by the ultra-high risk and/or basic symptom criteria. Besides analyses on treatment effects on conversion rate and functional outcome, age and intervention approach were examined as potential moderators. Based on data of 15 studies (n=1394), early intervention approaches generally produced significantly reduced conversion rates at 6-to 48-month follow-ups compared to the control conditions. However, they failed to achieve significantly greater functional improvements because both early intervention and control conditions produced similar positive effects. With regard to the intervention approach, both psychological and pharmacological interventions produced significant effects on conversion rates but not on functional outcome relative to the control conditions. Early intervention in youth samples was generally less effective than in predominantly adult samples. Six evidence-based recommendations for an early intervention in CHR samples could already be formulated although more studies to investigate the specificity of treatment effects and potential age effects in order to tailor interventions to the individual treatment needs and risk status are clearly needed.
Introduction
Each year 38.2% of the population of the European Union, i.e., 164.8 million persons, suffer from any mental disorder (Wittchen et al., 2011) . This is associated with huge societal and individual burden (Gustavsson et al., 2011; Whiteford et al., 2013) . Prevention has therefore become an integral part of European and international health care policies in order to reduce the prevalence and burden of mental disorders across the lifespan (EC, 2005 (EC, , 2008 Campion et al., 2012; Haro et al., 2014) .
Functional disability in psychotic disorders
Schizophrenia is among the seven leading causes of years lost to disability (YLDs) in adults in Europe (Wittchen et al., 2011) . This is mainly due to the fact that functional recovery rates have not changed substantially over the past 25 years, despite advances in pharmacological and psychological treatments (Jääskeläinen et al., 2013 , Shivashankar et al., 2013 . As a consequence, prevention of schizophrenia and psychotic disorders in general has attracted special interest (Solis, 2014) .
Functional impairments are already present before (Addington et al., 2011) and often worsen until the onset of psychosis (Häfner et al., 1999) . Furthermore, they are one of the main predictors of poor clinical outcome including conversion to psychosis (Granö et al., 2014) . This emphasizes the need to intervene as early as possible to avoid or at least diminish these burdens and thereby to prevent transition to manifest psychosis.
Prevention in clinical high risk states of psychoses
In psychosis research, an indicated prevention approach has been adopted that targets helpseeking persons who experience early signs of the emerging psychosis but do not meet diagnostic criteria with the ultimate goal to prevent the incidence of the disorder (McGlashan & Johannesson, 1999; McGorry et al., 1998 McGorry et al., , 2002 . Thus, indicated prevention faces two challenges: (1) the accurate identification of the target population and (2) their effective treatment. For the purpose of early detection, two complementary sets of clinical high risk (CHR) criteria have been developed: the basic symptom (Huber, 1966; Schultze-Lutter, 2009 ) and the ultra-high risk (UHR) approach (Miller et al., 2003; Yung et al., 2005) . Their evidence is systematically reviewed by and recommendations for their use are given in the accompanying European guidance on early detection (see Schultze-Lutter et al., this issue) . Notably, fulfilling these criteria only indicates an increased risk for developing psychosis which is always associated with an error probability resulting in false-positive predictions (Ruhrmann et al., 2010) . This has fueled ongoing debates about the risk of negative effects associated with the identification and treatment of CHR states of psychoses (e.g., stigmatization, financial loss) (e.g., Fusar-Poli et al., 2014; Nelson, 2014; ethics-chapter) .
Need for treatment in clinical high risk states of psychoses
In addition to the markedly increased risk for developing psychosis (Schultze-Lutter et al., this issue), the most important argument in favor of an intervention in CHR patients is the reported distress and stigmatization caused by their mental problems already at the time of referral to an early detection and intervention service (Kline et al., 2014; Rüsch et al., 2014a,b; Stowkowy et al., 2014) . This is reflected by their even higher levels of hopelessness, depressiveness, anxiety, and poor quality of life in comparison to other help-seeking patients and patients with firstepisode psychosis (Bechdolf et al., 2005; Lee et al., 2011; Pruessner et al., 2011; Granö et al., 2014a,b) . Accordingly, they often fulfill the diagnostic criteria for another mental disorder, in particular for depression, anxiety, and substance abuse or dependence, which require treatment (Woods et al., 2009; Hui et al., 2013; Fusar-Poli et al., 2014) . Furthermore, CHR patients exhibit poor coping skills, low self-efficacy, and excessive external attributions that resemble profiles of depressive patients and might unfavorably interact with their frequent depressive mood (Schmidt et al., 2014 ).
In addition, CHR patients demonstrate abnormalities in neuro-and social cognition with performances that are usually intermediate between those of healthy controls and schizophrenia patients (Fusar-Poli et al., 2013; Giuliano et al., 2013; Thompson et al., 2013; Bora et al., 2014; Brent et al., 2014) , and are associated with markedly impaired functional outcome and negative symptoms (Addington et al., 2009; Lin et al., 2011; Carrion et al., 2013; Olvet et al., 2013; Granö et al., 2014; Salokangas et al., 2014) . Consistent with the conceptualization of psychoses as neurodevelopmental disorders, these neuro-and social-cognitive abnormalities are also accompanied and possibly reflected by various abnormalities in functional and structural imaging (Smieskova et al., 2013; Bois et al., 2014) , in electrophysiological measures (Higuchi et al., 2013; Kayser et al., 2014) and neurochemistry (Leweke et al., 2012; Egerton et al., 2014; Gran et al., 2014) . In summary, CHR patients are -independent of any potential risk to develop psychosis in the future -certainly in need for treatment (Ruhrmann et al. 2010 ).
Requirements for early intervention approaches
In accordance with this obvious need for treatment, an increasing number of interventions have been evaluated in CHR samples in recent years (Ruhrmann et al., 2012; Okuzawa et al., 2014; Stafford et al., 2014) . With the primary goal to prevent conversion to psychosis, they have mainly built upon well-established interventions for adult schizophrenia patients and used conversion to psychosis as their primary outcome (McGorry et al., 2002; Morrison et al., 2004) . Other more recently developed interventions have taken into account that CHR patients not only suffer from risk symptoms but also from several other mental problems and have targeted a broader array of outcomes in various settings with various intervention techniques (e.g., intensive case management, multi-family psychoeducation) (Granö et al., 2014a,b; Marvin et al., 2014 ). Yet most "new generation" intervention studies have an uncontrolled single-group design, therefore lack methodological rigor, and were not included in recent meta-analyses on the efficacy of randomized controlled trials (RCTs) in CHR states (Cella & Preti, 2010; Marshall & Rathbone, 2011; Fusar-Poli et al., 2013; van der Gaag, 2013; Stafford et al., 2013; Hutton & Taylor, 2014) .
Current guidelines have not considered these "new generation" interventions (DGPPN, IEPA; NICE). Moreover, no sufficient evidence-based differential indication for the available interventions exists, which would require the examination of the treatment approach as a potential moderator variable in meta-analyses and/or in direct comparison in large RCTs with multiple treatment arms. In this context, age should also be studied as a potential moderator because CHR samples commonly include adolescents and young adults who differ in their social, emotional, and cognitive developmental state.
Aims
The main aim of this guidance paper on the early intervention in CHR states was therefore to evaluate the efficacy of intervention approaches in CHR patients that focus on both prevention of conversion to psychosis and improvement in functional outcome with special consideration of the potential moderating effects of age and intervention type. This served the ultimate goal to derive evidence-based recommendations on early intervention in CHR states assessed according to the recommendations provided by the EPA guidance on their early detection (see [Schultze-Lutter et al.] , this issue).
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). Furthermore, we inspected reference lists of all identified reviews and meta-analyses.
Selection criteria
We included all studies in our meta-analysis that (i) evaluated a psychological and/or pharmacological intervention including interventions with nutritional supplements and other substances, (ii) included a majority (>50%) of CHR patients as defined by the UHR and/or the basic symptom criteria, (iii) reported conversion rates and/or functional outcome as intervention outcome, and (iv) were published in English. Exclusion criteria were: (i) studies with samples that were also part of other studies included in our analyses with a larger sample size and/or a longer follow-up period, (ii) studies that were only published as an abstract or trial protocol, (iii) case-reports, and (iv) studies that used an observational naturalistic design without any specific intervention. 
Selection process and quality assessment
Psychological interventions (PSY)
